Founding investors Arix and Atlas Venture led a Series A funding round and were joined by AbbVie Ventures and RA Capital, with $50 million providing enough cash to last around three years.

An interesting high-risk addition to these trusts is Arix Bioscience. Arix invests in and builds unlisted biotechs making cutting-edge advances in life sciences. It has investments in 13 companies.

The Utah Utes and Arizona State Sun Devils face off on Friday, Oct. 11 in a key Big 12 matchup. Utah is a 5.5-point favorite ...

There was good news on this score in 2017, with investment through vehicles that fund the sector including Arix Bioscience (£113 million) and Biopharma Credit (£606 million). The data in the ...

Sai Gundavelli is founder and CEO of Solix Technologies, Inc. He previously held senior management roles at Cisco Systems and Arix Corp. Gundavelli is a member of the Churchill Club, TiE Charter ...

In November the trust made an all-share offer for biotech group Arix Bioscience. Arix has net assets of £232m, including £106m of cash, £56m in 15 listed but immature biotech investments ...